Scalp Sampling for Fetal Surveillance (FBS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01533701|
Recruitment Status : Unknown
Verified February 2012 by Maria Jonsson, Uppsala University Hospital.
Recruitment status was: Recruiting
First Posted : February 15, 2012
Last Update Posted : February 15, 2012
The purpose of this study is to compare lactate and total acid-base status in fetal scalp blood with lactate and total acid-base status in maternal blood and amniotic fluids to provide information on how lactate and base deficit correlates with scalp samples.
Furthermore, the investigators want to study whether angiogenic factors in fluids above may be a possible marker of asphyxia during labor.
|Condition or disease||Intervention/treatment||Phase|
|Fetal Hypoxia||Other: Fetal scalp blood scalp, amniotic fluid, maternal blood and umbilical cord sampling||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Biosampling for Markers of Hypoxia in Fetal Blood Scalp Sampling During Labor|
|Study Start Date :||January 2012|
|Estimated Primary Completion Date :||January 2014|
|Estimated Study Completion Date :||January 2014|
Other: Fetal scalp blood scalp, amniotic fluid, maternal blood and umbilical cord sampling
- Hypoxia [ Time Frame: 120 seconds ]Fetal blood sampling is conducted when a non reassurring cardiotocographic pattern occurs to detect fetal hypoxia during labor
- Subacute hypoxia [ Time Frame: 120 seconds ]Fetal blood sampling is conducted when a non reasurring cardiotocographic pattern occurs to detect fetal hypoxia during labor
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01533701
|Contact: Maria Jonsson, M.Dfirstname.lastname@example.org|
|Contact: Lena Liljeström, M.Demail@example.com|
|Delivery department Uppsala University hospital||Recruiting|
|Uppsala, Sweden, 75185|
|Contact: Maria Jonsson, M.D. +46186110000 firstname.lastname@example.org|
|Contact: lena Liljeström, M.D. +46186110000 email@example.com|
|Principal Investigator: Lena Liljeström, M.D.|